Pages that link to "Q42681844"
Jump to navigation
Jump to search
The following pages link to Michael Shattock (Q42681844):
Displayed 29 items.
- Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia (Q28342843) (← links)
- Inhibition of K+ transport through Na+, K+-ATPase by capsazepine: role of membrane span 10 of the α-subunit in the modulation of ion gating (Q28538680) (← links)
- Intensive training and reduced volume increases muscle FXYD1 expression and phosphorylation at rest and during exercise in athletes (Q30353316) (← links)
- Nitric oxide regulates cardiac intracellular Na⁺ and Ca²⁺ by modulating Na/K ATPase via PKCε and phospholemman-dependent mechanism (Q30413897) (← links)
- The intracellular region of FXYD1 is sufficient to regulate cardiac Na/K ATPase (Q33272408) (← links)
- Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. (Q34447034) (← links)
- Substrate recognition by the cell surface palmitoyl transferase DHHC5. (Q34709144) (← links)
- Multiple quantum filtered (23)Na NMR in the Langendorff perfused mouse heart: Ratio of triple/double quantum filtered signals correlates with [Na]i (Q36042252) (← links)
- FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C. (Q37216812) (← links)
- Novel regulation of cardiac Na pump via phospholemman. (Q38106767) (← links)
- Cardiac Dysautonomia in Huntington's Disease (Q38233997) (← links)
- Geometrical considerations in cardiac electrophysiology and arrhythmogenesis (Q38639128) (← links)
- Expression and regulation of type 2A protein phosphatases and alpha4 signalling in cardiac health and hypertrophy (Q41842719) (← links)
- Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman (Q42914932) (← links)
- Channel "selectivity" and evolution Has evolutionary pressure and natural selection provided the ATP sensitive potassium channel in the myocardium as an endogenous protection against ischaemic heart disease? (Q44972245) (← links)
- Selective superoxide generation within mitochondria by the targeted redox cycler MitoParaquat (Q46656679) (← links)
- Increased oxidative metabolism following hypoxia in the type 2 diabetic heart, despite normal hypoxia signalling and metabolic adaptation (Q47917866) (← links)
- Phospholemman-dependent regulation of the cardiac Na/K-ATPase activity is modulated by inhibitor-1 sensitive type-1 phosphatase (Q48756558) (← links)
- Sympathetic Nervous Regulation of Calcium and Action Potential Alternans in the Intact Heart. (Q49264941) (← links)
- Action potential duration and endocardial modulation of myocardial contraction in the ferret (Q68223500) (← links)
- Heart failure leads to altered β2-adrenoceptor/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain (Q91234366) (← links)
- Ablation of Toll-like receptor 9 attenuates myocardial ischemia/reperfusion injury in mice (Q92499049) (← links)
- The Amplitude-Normalized Area of a Bipolar Electrogram as a Measure of Local Conduction Delay in the Heart (Q96170057) (← links)
- Control of protein palmitoylation by regulating substrate recruitment to a zDHHC-protein acyltransferase (Q98184275) (← links)
- COVID-19 and haemoglobin oxygen affinity: some clarity? (Q98508454) (← links)
- Intracellular sodium elevation reprograms cardiac metabolism (Q98784818) (← links)
- 14-3-3 binding creates a memory of kinase action by stabilizing the modified state of phospholamban (Q98891065) (← links)
- Off-target effects of SGLT2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart (Q101147177) (← links)
- (Q105672218) (redirect page) (← links)